US Pharma MarketingThe large pharma’s promising new candidate retatrutide is still in the clinic. But Lilly is already fighting a web of illicit sellers for the drug online.
Lilly is fighting a black market for its new obesity drug even before it launches
The large pharma’s promising new candidate retatrutide is still in the clinic. But Lilly is already fighting a web of illicit sellers for the drug online.
Source: PharmaVoice